SARM1 and ischemia: Our first aim was to evaluate whether eliminating SARM1 activity can enhance long-term RGC survival in focal axonal ischemia, using the rat rNAION model in a recently developed rat SARM1(−) knockout line generated in an SD rat strain using Crispr-Cas9 technology [38].